US Stock MarketDetailed Quotes
SLRX Salarius Pharmaceuticals
- 1.9800
- -0.2000-9.17%
Close Jul 12 16:00 ET
- 2.0200
- +0.0400+2.02%
Post 19:20 ET
1.18MMarket Cap-122P/E (TTM)
2.2200High1.8799Low159.02KVolume2.2200Open2.1800Pre Close317.39KTurnover28.36%Turnover RatioLossP/E (Static)597.05KShares9.919252wk High0.32P/B1.11MFloat Cap1.810052wk Low--Dividend TTM560.78KShs Float124099.9504Historical High--Div YieldTTM15.60%Amplitude1.8100Historical Low1.9950Avg Price1Lot Size
About Salarius Pharmaceuticals Company
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Company Profile
SymbolSLRX
Company NameSalarius Pharmaceuticals
Listing DateJan 29, 2015
Issue Price16.00
Founded2014
CEOMr. David J. Arthur
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite X
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-832-834-6992
Websitehttp://salariuspharma.com
Company Executives
- Name
- Position
- Salary
- David J. Arthur
- Chief Executive Officer
- 544.60K
- Mark J. Rosenblum
- Executive Vice President, Finance and Chief Financial Officer
- 494.55K
- Dr. William K. McVicar, PhD
- Chairman of the Board
- 82.26K
- Tess Burleson
- Independent Director
- 64.76K
- Dr. Bruce McCreedy, PhD
- Independent Director
- 45.26K
- Jonathan I. Lieber, M.B.A.
- Independent Director
- 53.76K
- Arnold C. Hanish
- Independent Director
- 67.26K
- Dr. Paul Lammers, M. Sc.,M.D.
- Lead Independent Director
- 76.76K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg